Moderna Reports Preliminary Results of COVID-19 Vaccine to Be 94.5% Effective
(CBS Detroit) - Moderna says preliminary results show it's Phase Three vaccine is 94.5% effective in trials.
This comes after Pfizer said last week that its vaccine was more than 90% effective.
Among 30,000 participants receiving the 2 dose Moderna vaccine, there were 95 cases of symptomatic COVID.
All but five were in the placebo arm.
There were no reports of serious side effects.
© 2020 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.
